Is Fermenta Biotech a good stock to invest in?

Fermenta Biotech can be analyzed on the following key metrics - TTM P/E: 10.35 Sector P/E: 22.43 Dividend Yield: 0.77% D/E ratio: -

Fermenta Biotech Share Price

Sector: Biotechnology & Drugs

Powered by

323.55 +6.30 (1.99%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 323.45

Today’s High 323.55

52 Week Low 163.00

52 Week High 449.00

Key Metrics

Market Cap (In Cr) 952.24
Beta 0.46
Div. Yield (%) 0.77
P/B 2.6
TTM P/E 10.35
Sector P/E 22.43
D/E 0
Open Price 323.55
Prev Close 317.25

View All Metrics

Fermenta Biotech Analysis

Price Analysis

1 Week

2.62%
3 Months

18.28%
6 Month

-12.84%
YTD

-11.1%
1 Year

94.68%

Risk Meter

71% Low risk
71% Moderate risk
71% Balanced Risk
71% High risk
71% Extreme risk

Fermenta Biotech News

Concord Biotech share price has rallied more than 37% in the last three months. (Photo: Company Website)

Premium

Choice Broking initiates coverage on Concord Biotech with ‘Outperform’ call

2 min read . 02 Jan 2024

Fermenta Biotech Limited (FBL) is a pioneer in immobilized enzyme technology with the mission to contribute to the emerging transformation of Biocatalysis.

Premium

FBL gives Aurigene Pharma license to manufacture Molnupiravir via enzymatic tech

1 min read . 21 Jan 2022

Premium

Prashant Nagre elevated to the position of MD of Fermenta Biotech Limited

2 min read . 07 May 2021

View More News

Fermenta Biotech Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
469.48

Selling/ General/ Admin Expenses Total
65.1

Depreciation/ Amortization
24.22

Other Operating Expenses Total
147.17

Total Operating Expense
383.9

Operating Income
85.58

Net Income Before Taxes
83.21

Net Income
76.86

Diluted Normalized EPS
26.35

Period
2024

Total Revenue
335.66

Selling/ General/ Admin Expenses Total
101.77

Depreciation/ Amortization
24.54

Other Operating Expenses Total
43.73

Total Operating Expense
339.97

Operating Income
-4.31

Net Income Before Taxes
-9.87

Net Income
-23.06

Diluted Normalized EPS
-6.24

Period
2023

Total Revenue
349.94

Selling/ General/ Admin Expenses Total
92.38

Depreciation/ Amortization
25.65

Other Operating Expenses Total
57.24

Total Operating Expense
388

Operating Income
-38.06

Net Income Before Taxes
-51.87

Net Income
-51.5

Diluted Normalized EPS
-11.36

Period
2022

Total Revenue
398.52

Selling/ General/ Admin Expenses Total
95.48

Depreciation/ Amortization
22.73

Other Operating Expenses Total
56.34

Total Operating Expense
362.6

Operating Income
35.92

Net Income Before Taxes
26.94

Net Income
15.45

Diluted Normalized EPS
5.33

Period
2021

Total Revenue
377.29

Selling/ General/ Admin Expenses Total
90.03

Depreciation/ Amortization
17.75

Other Operating Expenses Total
47.05

Total Operating Expense
314.67

Operating Income
62.62

Net Income Before Taxes
51.63

Net Income
45.51

Diluted Normalized EPS
15.73

Period
2020

Total Revenue
292.95

Selling/ General/ Admin Expenses Total
121.77

Depreciation/ Amortization
12.43

Other Operating Expenses Total
4.01

Total Operating Expense
242.56

Operating Income
50.39

Net Income Before Taxes
43.42

Net Income
59.53

Diluted Normalized EPS
13.4

Period
2019

Total Revenue
404.67

Selling/ General/ Admin Expenses Total
131.17

Depreciation/ Amortization
9.29

Other Operating Expenses Total
7.32

Total Operating Expense
267.1

Operating Income
137.57

Net Income Before Taxes
128.71

Net Income
117.45

Diluted Normalized EPS
40.87

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Fermenta Biotech Technical

Moving Average SMA

5 Day311.53
10 Day321.98
20 Day323.51

50 Day298.54
100 Day295.56
300 Day319.18

Fermenta Biotech Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Anuh Pharma
212.1
4.05
1.95
249.95
148.05
1062.88

Aayush Wellness
198.95
3.9
2
195.05
16.8
968.32

Fermenta Biotech
323.55
6.3
1.99
449
163
952.24

Wanbury
285.2
9.8
3.56
330
151.1
935.97

Kopran
185.55
0.55
0.3
369.2
157
898.85

Fermenta Biotech Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

28-May-25
Audited Results, Final Dividend & ESOP

11-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

12-Aug-24
Quarterly Results

27-May-24
Audited Results & Final Dividend

12-Feb-24
Quarterly Results

08-Nov-23
Quarterly Results

11-Aug-23
Quarterly Results

29-May-23
Audited Results & Final Dividend

10-Feb-23
Quarterly Results

Meeting Date
Announced on
Purpose

12-Aug-25
28-May-25
AGM

04-May-25
02-Apr-25
POM

28-Dec-24
26-Nov-24
POM

12-Aug-24
27-May-24
AGM

19-Mar-24
16-Feb-24
POM

29-Sept-23
11-Aug-23
AGM

12-Aug-22
30-May-22
AGM

10-Jun-22
13-May-22
POM

03-Sept-21
29-Jun-21
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

28-May-25
06-Aug-25
-
2.5

27-May-24
06-Aug-24
06-Aug-24
1.25

29-May-23
22-Sept-23
22-Sept-23
1.25

20-May-22
05-Aug-22
04-Aug-22
1.25

29-Jun-21
-
25-Aug-21
2.5

View All

Company Profile

ABOUT Fermenta Biotech

Industry Biotechnology & Drugs
ISIN INE225B01021
BSE Code 506414

Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.

MANAGEMENT

Prashant Nagre Chief Executive Officer, Managing Director, Director
Krishna Datla Executive Vice Chairman of the Board
Sumesh Gandhi Chief Financial Officer
Anupama Datla Executive Director
Satish Varma Executive Director
Varadvinayak Khambete Company Secretary

FERMENTA BIOTECH SUMMARY

Fermenta Biotech is trading 1.99% upper at Rs 323.55 as compared to its last closing price. Fermenta Biotech has been trading in the price range of 323.55 & 323.45. Fermenta Biotech has given -11.1% in this year & 2.62% in the last 5 days.

Fermenta Biotech has TTM P/E ratio 10.35 as compared to the sector P/E of 22.43.

The company posted a net profit of 34.39 Crores in its last quarter.

Listed peers of Fermenta Biotech include Anuh Pharma (1.95%), Aayush Wellness (2%), Fermenta Biotech (1.99%) etc.

Fermenta Biotech has a 0.89% promoter holding & 0.89% public holding.

FAQs about Fermenta Biotech

Fermenta Biotech is trading at 323.55 as on 27 Jun, 2025 3:15:00 PM. This is 1.99% upper as compared to its previous closing price of 317.25

The market capitalization of Fermenta Biotech is 952.24 Cr as on 27 Jun, 2025 3:15:00 PM.

The 52 wk high for Fermenta Biotech is 449.00 whereas the 52 wk low is 163.00

Fermenta Biotech can be analyzed on the following key metrics -

TTM P/E: 10.35
Sector P/E: 22.43
Dividend Yield: 0.77%
D/E ratio: -

Fermenta Biotech reported a net profit of 76.86 Cr in 2025.

Fermenta Biotech Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Fermenta Biotech Share Price

Price Range

Key Metrics

Fermenta Biotech Analysis

Fermenta Biotech News

Choice Broking initiates coverage on Concord Biotech with ‘Outperform’ call

FBL gives Aurigene Pharma license to manufacture Molnupiravir via enzymatic tech

Prashant Nagre elevated to the position of MD of Fermenta Biotech Limited

Fermenta Biotech Financials

Forecast

Forecast

Forecast

Fermenta Biotech Technical

Fermenta Biotech Peers

Fermenta Biotech Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Fermenta Biotech

MANAGEMENT

FERMENTA BIOTECH SUMMARY

FAQs about Fermenta Biotech

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue